The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer

Signal Transduct Target Ther. 2021 Feb 21;6(1):73. doi: 10.1038/s41392-020-00452-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / diagnostic imaging
  • Adenocarcinoma of Lung / therapy*
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism
  • Female
  • Humans
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / therapy*
  • Male
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / metabolism
  • Protein Kinase Inhibitors / administration & dosage*

Substances

  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors